These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10957997)

  • 1. Radioligand binding studies. Pharmacological profiles of cloned Y-receptor subtypes.
    McCrea KE; Herzog H
    Methods Mol Biol; 2000; 153():231-9. PubMed ID: 10957997
    [No Abstract]   [Full Text] [Related]  

  • 2. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Y4 receptor in different species. Functional expression and binding.
    Lundell I; Berglund MM; Larhammar D
    Methods Mol Biol; 2000; 153():45-51. PubMed ID: 10957983
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human type 2 neuropeptide Y receptor gene. Isolation and characterization.
    Ammar DA; Thompson DA
    Methods Mol Biol; 2000; 153():25-43. PubMed ID: 10957982
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropeptide Y receptor-specifically modulates human neutrophil function.
    Bedoui S; Kromer A; Gebhardt T; Jacobs R; Raber K; Dimitrijevic M; Heine J; von Hörsten S
    J Neuroimmunol; 2008 Mar; 195(1-2):88-95. PubMed ID: 18343509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
    Schneider E; Mayer M; Ziemek R; Li L; Hutzler C; Bernhardt G; Buschauer A
    Chembiochem; 2006 Sep; 7(9):1400-9. PubMed ID: 16888730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas.
    Wittmann W; Loacker S; Kapeller I; Herzog H; Schwarzer C
    Neuroscience; 2005; 136(1):241-50. PubMed ID: 16198492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptors.
    Keller M; Bernhardt G; Buschauer A
    ChemMedChem; 2011 Sep; 6(9):1566-71. PubMed ID: 21732539
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
    Rodriguez M; Audinot V; Dromaint S; Macia C; Lamamy V; Beauverger P; Rique H; Imbert J; Nicolas JP; Boutin JA; Galizzi JP
    Biochem J; 2003 Feb; 369(Pt 3):667-73. PubMed ID: 12398768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR; Schober DA; Morin M; Berglund MM
    Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor.
    Yao BB; Witte DG; Miller TR; Carr TL; Kang CH; Cassar S; Faghih R; Bennani YL; Surber BW; Hancock AA; Esbenshade TA
    Neuropharmacology; 2006 Mar; 50(4):468-78. PubMed ID: 16316670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y-family receptors Y6 and Y7 in chicken. Cloning, pharmacological characterization, tissue distribution and conserved synteny with human chromosome region.
    Bromée T; Sjödin P; Fredriksson R; Boswell T; Larsson TA; Salaneck E; Zoorob R; Mohell N; Larhammar D
    FEBS J; 2006 May; 273(9):2048-63. PubMed ID: 16640567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of human neuropeptide Y receptor subtype five specific antagonists using a luciferase reporter gene assay.
    Beauverger P; Rodriguez M; Nicolas JP; Audinot V; Lamamy V; Dromaint S; Nagel N; Macia C; Léopold O; Galizzi JP; Caignard DH; Aldana I; Monge A; Chomarat P; Boutin JA
    Cell Signal; 2005 Apr; 17(4):489-96. PubMed ID: 15601626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor.
    Kakui N; Tanaka J; Tabata Y; Asai K; Masuda N; Miyara T; Nakatani Y; Ohsawa F; Nishikawa N; Sugai M; Suzuki M; Aoki K; Kitaguchi H
    J Pharmacol Exp Ther; 2006 May; 317(2):562-70. PubMed ID: 16436501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain.
    Dumont Y; Moyse E; Fournier A; Quirion R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):99-108. PubMed ID: 15947033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.